However, patients with adverse events are much older, had a higher proportion of type 2 diabetes mellitus (T2DM) and multivessel coronary artery disease (MVD), a poorer Killip classification, higher levels of N-terminal fragment of pro B-type natriuretic peptide (NT-proBNP) and white blood cell count (WBC) compared to patients with non-events. The gene discussed is NPPB; the disease is coronary artery disorder.